These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9649156)

  • 41. Genetic and epigenetic changes in aberrant crypt foci and serrated polyps.
    Suehiro Y; Hinoda Y
    Cancer Sci; 2008 Jun; 99(6):1071-6. PubMed ID: 18384435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns.
    Yano Y; Konishi K; Yamochi T; Katagiri A; Nozawa H; Suzuki H; Toyota M; Kubota Y; Muramoto T; Kobayashi Y; Tojo M; Konda K; Makino R; Kaneko K; Yoshikawa N; Ota H; Imawari M
    Am J Gastroenterol; 2011 Jul; 106(7):1351-8. PubMed ID: 21427714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
    Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
    Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon.
    Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Grankin M; Bernheim J
    Am J Surg; 1997 Oct; 174(4):425-30. PubMed ID: 9337168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The natural history of aberrant crypt foci.
    Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
    Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between the nature of mucus and crypt multiplicity in aberrant crypt foci in the rat colon.
    Uchida K; Kado S; Onoue M; Tohyama K
    Jpn J Cancer Res; 1997 Sep; 88(9):807-14. PubMed ID: 9369927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. One year recurrence of aberrant crypt foci.
    Pinsky PF; Fleshman J; Mutch M; Rall C; Charabaty A; Seligson D; Dry S; Umar A; Schoen RE
    Cancer Prev Res (Phila); 2010 Jul; 3(7):839-43. PubMed ID: 20570885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa.
    Glebov OK; Rodriguez LM; Soballe P; DeNobile J; Cliatt J; Nakahara K; Kirsch IR
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2253-62. PubMed ID: 17119054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous development of aberrant crypt foci in F344 rats.
    Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer.
    Stevens RG; Swede H; Heinen CD; Jablonski M; Grupka M; Ross B; Parente M; Tirnauer JS; Giardina C; Rajan TV; Rosenberg DW; Levine J
    Cancer Lett; 2007 Apr; 248(2):262-8. PubMed ID: 16950561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
    Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
    Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
    Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
    Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colonic aberrant crypts may originate from impaired fissioning: relevance to increased risk of neoplasia.
    Kristt D; Bryan K; Gal R
    Hum Pathol; 1999 Dec; 30(12):1449-58. PubMed ID: 10667423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].
    Katsuki S; Oui M; Takayama T; Takahashi Y; Shuichi N; Niitsu Y
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):379-84. PubMed ID: 9695076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions.
    McLellan EA; Medline A; Bird RP
    Cancer Res; 1991 Oct; 51(19):5270-4. PubMed ID: 1913650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CpG island methylation in aberrant crypt foci of the colorectum.
    Chan AO; Broaddus RR; Houlihan PS; Issa JP; Hamilton SR; Rashid A
    Am J Pathol; 2002 May; 160(5):1823-30. PubMed ID: 12000733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of dysplasia in human colonic aberrant crypt foci.
    Siu IM; Pretlow TG; Amini SB; Pretlow TP
    Am J Pathol; 1997 May; 150(5):1805-13. PubMed ID: 9137103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
    Magnuson BA; Carr I; Bird RP
    Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
    Kowalczyk M; Orłowski M; Siermontowski P; Mucha D; Zinkiewicz K; Kurpiewski W; Zieliński E; Kowalczyk I; Pedrycz A
    BMC Cancer; 2018 Feb; 18(1):213. PubMed ID: 29466973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
    Lasko CM; Bird RP
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):49-55. PubMed ID: 7894324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.